Mutual Advisors LLC Sells 753 Shares of SPDR S&P Biotech ETF $XBI

Mutual Advisors LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,545 shares of the exchange traded fund’s stock after selling 753 shares during the quarter. Mutual Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,362,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of XBI. Sowell Financial Services LLC bought a new stake in SPDR S&P Biotech ETF in the first quarter worth $686,000. Insigneo Advisory Services LLC bought a new stake in SPDR S&P Biotech ETF in the first quarter worth $217,000. Cornerstone Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 11.8% in the first quarter. Cornerstone Wealth Management LLC now owns 6,460 shares of the exchange traded fund’s stock worth $524,000 after buying an additional 684 shares during the last quarter. Kingswood Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 10.9% in the first quarter. Kingswood Wealth Advisors LLC now owns 5,309 shares of the exchange traded fund’s stock worth $429,000 after purchasing an additional 522 shares during the period. Finally, Institute for Wealth Management LLC. increased its stake in SPDR S&P Biotech ETF by 2.0% in the first quarter. Institute for Wealth Management LLC. now owns 9,676 shares of the exchange traded fund’s stock worth $785,000 after purchasing an additional 186 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1%

XBI stock opened at $107.80 on Friday. The business’s fifty day simple moving average is $96.06 and its two-hundred day simple moving average is $86.60. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $110.96. The firm has a market cap of $6.42 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.